Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Rheumatoid Arthritis

  Free Subscription

Articles published in Curr Opin Rheumatol

Retrieve available abstracts of 14 articles:
HTML format

Single Articles

    November 2023
  1. COHEN S, Reddy V
    Janus kinase inhibitors: efficacy and safety.
    Curr Opin Rheumatol. 2023;35:429-434.
    PubMed     Abstract available

    September 2023
  2. NEUMANN E, Heck C, Muller-Ladner U
    Recent developments in the synovial fibroblast pathobiology field in rheumatoid arthritis.
    Curr Opin Rheumatol. 2023 Sep 13. doi: 10.1097/BOR.0000000000000978.
    PubMed     Abstract available

    May 2023
  3. DEFOE M, Bermas BL
    Rheumatologic immune checkpoint inhibitor-related adverse events.
    Curr Opin Rheumatol. 2023;35:141-148.
    PubMed     Abstract available

    April 2023
  4. MANTEL I, Fein MR, Donlin LT
    Emerging synovial cell states in rheumatoid arthritis as potential therapeutic targets.
    Curr Opin Rheumatol. 2023 Apr 10. doi: 10.1097/BOR.0000000000000940.
    PubMed     Abstract available

    February 2023
  5. MINHAS D, Murphy A, Clauw DJ
    Fibromyalgia and centralized pain in the rheumatoid arthritis patient.
    Curr Opin Rheumatol. 2023 Feb 13. doi: 10.1097/BOR.0000000000000929.
    PubMed     Abstract available

  6. ZACCARDELLI A, Wallace ZS, Sparks JA
    Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic.
    Curr Opin Rheumatol. 2023 Feb 8. doi: 10.1097/BOR.0000000000000930.
    PubMed     Abstract available

    November 2022
  7. KINGSMORE KM, Lipsky PE
    Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupus.
    Curr Opin Rheumatol. 2022;34:374-381.
    PubMed     Abstract available

    September 2022
  8. LORENTZON M, Abrahamsen B
    Osteoporosis epidemiology using international cohorts.
    Curr Opin Rheumatol. 2022;34:280-288.
    PubMed     Abstract available

    July 2022
  9. IZNARDO H, Puig L
    Beyond plaque psoriasis - pathogenesis and treatment of other psoriasis phenotypes.
    Curr Opin Rheumatol. 2022;34:225-234.
    PubMed     Abstract available

    May 2022
  10. LUIS M, Boers M, Saag K, Buttgereit F, et al
    The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence.
    Curr Opin Rheumatol. 2022;34:179-186.
    PubMed     Abstract available

    March 2022
  11. ANASTASIOU C, Yazdany J
    Review of publications evaluating opioid use in patients with inflammatory rheumatic disease.
    Curr Opin Rheumatol. 2022;34:95-102.
    PubMed     Abstract available

    November 2021
  12. BIRRU TALABI M, Himes KP, Clowse MEB
    Optimizing reproductive health management in lupus and Sjogren's syndrome.
    Curr Opin Rheumatol. 2021;33:570-578.
    PubMed     Abstract available

    September 2021
  13. SATTUI SE, Crow MK, Navarro-Millan I
    The role of immunomodulatory medications in the treatment of COVID-19.
    Curr Opin Rheumatol. 2021;33:431-445.
    PubMed     Abstract available

  14. RANDELL RL, Becker ML
    Safety updates in novel therapeutics for pediatric rheumatic disease.
    Curr Opin Rheumatol. 2021;33:403-408.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.